Navigation Links
Tengion Provides Business Update and Reports Third Quarter 2012 Financial Results

778General and administrative1,3831,1985,1974,01745,910Depreciation7181062,81635723,509Impairment of property and equipment————7,371Other expense26389951301,835Total operating expenses4,9643,78018,58712,425204,403Loss from operations(4,964)(3,780)(18,587)(12,425)(204,403)Interest income12139128,524Interest expense(193)(469)(666)(794)(15,683)Change in fair value of warrant liability4,185(324)14,12336716,865Net loss$





(194,697)Basic and diluted net loss attributable to common stockholders per share$




(5.41)Shares used in computing basic and diluted net loss attributable to common stockholders:Basic and diluted2,3542,4502,0942,371 

(A Development-Stage Company)BALANCE SHEET DATA
(in thousands)
(unaudited) December 31,2011September 30, 2012Cash and cash equivalents$


1,374Short-term investments6,066—Total assets17,8173,894Warrant liability2,5112,144Total debt (including current portion)4,9874,852Total liabilities12,80211,286Total stockholders' equity (deficit)5,015(7,392)TENGION, INC.
(in thousands, except per share data)
(unaudited)In accordance with Regulation G of the Securities and Exchange Commission, the table set forth below reconciles certain financial measures used in this press release that were not calculated in accordance with generally accepted accounting principles, or GAAP, with the most directly comparable financial measure calculated in accordance with GAAP. Three Months Ended September 30,Nine Months Ended

September 30,2011201220112012

SOURCE Tengion, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting
2. Tengion Announces Relocation of Corporate Headquarters to Current Facility in Winston-Salem, North Carolina
3. Tengion to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
4. New Resource Provides Herb Industry With Sources of Quality Specifications
5. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
6. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
7. Health Diagnostic Laboratory, Inc. Provides Largest Corporate Gift in Science Museum of Virginias History
8. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
9. Oxford Finance Provides $15 Million Senior Secured Credit Facility to Private Equity Backed Healthcare Services Company
10. Insmed Incorporated Provides Corporate Update
11. Van Andel Research Institute Study Provides New Details of Fundamental Cellular Process
Post Your Comments:
(Date:1/22/2015)... 22, 2015   GenoSpace , a precision medicine software company ... the broad use of genomic, imaging and other biomedical data ... Michelle Munson , CEO of Aspera, an IBM Company, ... - "We are pleased ...
(Date:12/24/2014)... , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: ... areas, announced the closing of an underwritten public offering of ... to an aggregate 3,500,000 shares of common stock, at an ... The warrants have a per share exercise price of $5.00, ...
(Date:12/24/2014)... 2014 GMO corn cases filed across the ... the process of being consolidated in a Kansas federal court ... AG MIR 162 Corn Litigation, MDL No. 2591 in the ... of the Syngenta GMO corn multidistrict litigation (MDL) has been ...
(Date:12/24/2014)... York (PRWEB) December 23, 2014 According to ... Long Island Affiliate of ITRA Global, the national office market ... steady recovery. This is evidenced by the third quarter’s ... stock market. Low energy costs have held inflation down ...
Breaking Biology Technology:GenoSpace Expands Board with Appointment of Michelle Munson 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3
... Products Industry Leader, DEERFIELD, Ill., Sept. 12 ... it has been named 2007,Medical Products Industry Leader of ... Dow Jones Sustainability North America Index,(DJSI North America). This ... listed in the DJSI and the sixth year the ...
... 12 Leading scientists,from around the world will ... approaches for producing life-saving vaccines and,antibodies. More than ... "New Cells for New Vaccines II: Focus on ... du Pont. The international,scientific workshop is being organized ...
... 12 Human Pheromone,Sciences, Inc. (OTC Bulletin Board: ... of an exclusive Agency Agreement with Brand,Intelligence Group, ... Attraction(R) brand, which contains its proprietary and patented,human ... Agreement, HPS and BIG will work together to,develop ...
Cached Biology Technology:Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year 2International Scientific Workshop Focuses on New Methods for Vaccine and Antibody Development 2Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand 2
(Date:1/22/2015)... 22, 2015   EyeLock, Inc. , a market leader of ... Steve Gerber to the new role of Senior Vice ... leading development of mobile platforms and wearable solutions for EyeLock,s ... innovation in the semiconductor industry to his role at EyeLock, ...
(Date:12/22/2014)... DUBLIN , Dec. 22, 2014 Research and ... the addition of the "The Global Watermarking ... ... global digital media watermarking and fingerprinting markets. Watermarking ...
(Date:12/19/2014)... Inc., the leading personal genetics company, today announced the publication ... of individuals from across the United States ... hundred years ago, the United States ... continents. This study illuminates how American history and the ongoing ...
Breaking Biology News(10 mins):EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2The Global Watermarking and Fingerprinting Markets 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4
... Discovery Fund (LSDF) today announced $1.1 million in ... and non-profit organizations to foster the translation of ... marketplace. Two of the five new ... invented within Washington-based companies. HeatFlow Technologies (principal investigator ...
... Researchers at Queen Mary University of London have shown for ... on to perform is controlled by primary cilia tiny hair-like ... of becoming any cell type within the body through the ... for application in the development of new therapies for a ...
... has known for years that people who drink moderate amounts ... general, they are healthier and have better cardiovascular function that ... research from Oregon Health & Science University adds a fascinating ... help it fight off infection. The research, published Dec. ...
Cached Biology News:Life Sciences Discovery Fund announces R&D grants 2Study: Moderate alcohol consumption boosts body's immune system 2Study: Moderate alcohol consumption boosts body's immune system 3
Chicken polyclonal to QPRT ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to Internal sequence amino acids 123-237 of Human QPRT Entrez Gene ID: 23475 ...
Antibody Diluent for IHC 125 ml...
QPRT Antibody...
Biology Products: